The Transatlantic Trade and Investment Partnership: From Hot TTIP to Oblivion?

September 5, 2014
Reflector

Reflector is Pharm Exec's Brussels correspondent.

Pharmaceutical Executive

Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean.

Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean. TTIP, the Transatlantic Trade and Investment Partnership, was the hot tip for a 2014 success story. But as summer slides away and autumn beckons, the latest read-out of progress suggests that rather than remaining a hot tip, TTIP now risks being tipped into oblivion.

For the rest of this article, click here.